RT Journal Article
SR Electronic
T1 Correction: <em>Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study</em>
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000437corr1
DO 10.1136/jitc-2019-000437corr1
VO 8
IS 2
YR 2020
UL http://jitc.bmj.com/content/8/2/e000437corr1.abstract